First Turn Management »

Vaxcyte shares owned by First Turn Management

Quarter-by-quarter ownership of Vaxcyte (PCVX) shares owned by First Turn Management from 13F filings

Historical chart of First Turn Management investment in Vaxcyte

Tip: Access up to 7 years of quarterly data

All positions including Vaxcyte held by First Turn Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Vaxcyte by First Turn Management

Quarter filed Position value Share count Share price at filing
2023-12-31 $23M 358k 62.80

More positions owned by First Turn Management

Cytokinetics Com New (CYTK)
Cymabay Therapeutics
Vertex Pharmaceuticals Incorporated (VRTX)
Argenx Se Sponsored Adr (ARGX)
Xenon Pharmaceuticals (XENE)
Krystal Biotech (KRYS)
Legend Biotech Corp Sponsored Ads (LEGN)
Karuna Therapeutics Ord
Transmedics Group (TMDX)
Insulet Corporation (PODD)
Day One Biopharmaceuticals I (DAWN)
Mirum Pharmaceuticals (MIRM)
Verona Pharma Sponsored Ads (VRNA)
Dex (DXCM)
Axsome Therapeutics (AXSM)

View all positions for First Turn Management

Top funds holding Vaxcyte

Vanguard Group
RA Capital Management
Henderson Group
Wellington Management Company
T. Rowe Price Associates
Alliancebernstein
Fred Alger Management
Jennison Associates
Westfield Capital Management Company
Braidwell
Frazier Life Sciences Management
OrbiMed Advisors
Commodore Capital
Perceptive Advisors
Franklin Resources

View all funds holding Vaxcyte